Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
This is not a financial advice!
Rel. Vol. on 03/15/2024 at 1.62 - not really high but we might building up momentum
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
1.20 must been broken for entry
Keep an eye on 1.3 needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 1.0
TP approx. 2.18
Most info on the chart.
Trade carefully!
This is not a financial advice!
Rel. Vol. on 03/15/2024 at 1.62 - not really high but we might building up momentum
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
1.20 must been broken for entry
Keep an eye on 1.3 needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 1.0
TP approx. 2.18
Most info on the chart.
Trade carefully!
Trade closed: stop reached
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.